Urology Devices Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User, and Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT

Report Code: MD 4682 Nov, 2023, by marketsandmarkets.com

The global urology devices market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Investments by hospitals in procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices. Moreover, increased demand for MIS robotic systems is expected to increase in the coming years, which is expected to propel the market growth.

Attractive Opportunities in the Urology Devices Market

Urology Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Urology Devices Market

Urology Devices Market Dynamics

DRIVER: Rising incidence of urological diseases

With the rising incidence of urological diseases and surgical procedures for their treatment, the demand for urology devices has increased. The prevalence of urological conditions, such as chronic kidney diseases (CKD), end-stage renal diseases (ESRD), urinary incontinence, kidney and ureteral stones, and bladder and prostate cancer, have increased significantly globally. Patients with chronic conditions often require regular procedures to manage their conditions, while surgical procedures, especially major surgeries, necessitate significant technologically advanced devices for safe and successful outcomes. This is expected to positively impact the market. According to the American Kidney Fund (AKF), in 2022, kidney diseases affected 37 million Americans, with 807,000 living with kidney failure, over 562,000 undergoing dialysis, and more than 245,000 receiving kidney transplants.

RESTRAINT: High degree of consolidation among key players

Intense competition characterizes this market, which is heavily dominated by major players. Significant capital investments, elevated R&D and manufacturing costs make entry difficult for newcomers. Moreover, the established top-tier companies benefit from brand loyalty, further solidifying their market position. The considerable consolidation within the industry serves as a formidable barrier for potential entrants. For instance, according to a 2020 article in Investigative and Clinical Urology, many companies have expressed keen interest in entering this global market and developing their own surgical robotic systems.

OPPORTUNITY: Potential growth opportunities in emerging economies

The market's growth is significantly driven by the private healthcare sector's expansion, aimed at meeting the increasing demands of the expanding middle-class population. The middle-class population in the Asia Pacific is expected to increase to 66% by 2030 from 28% in 2009 (Source: OECD). According to the same source, the purchasing power of the growing middle-class population is expected to increase to 59% by 2020 from 23% in 2009. As disposable incomes increase and the middle class requires more medical attention, manufacturers of urology devices must devise new strategies to address this demand. Emerging markets, yet to be fully explored by major players, represent significant untapped market potential.

CHALLENGE: Product recalls witnessed by major market players

Product recalls in the medical device industry occur when a product is found to be defective, potentially harmful, or not in compliance with regulatory standards. Recalls can be initiated voluntarily by the manufacturer or mandated by regulatory agencies. The market growth is significantly affected by the product recalls due to the significant financial and reputational impacts on manufacturers. Regulatory bodies like the FDA in the United States or the CE Marking system in Europe oversee these recalls to ensure patient safety and compliance with regulations. Frequent product recalls during 2020–2021 witnessed by giant companies, such as Fresenius Medical Care, Olympus Corporation, Karl Storz, and Cook Medical, pose a major challenge to the growth of the urology device market.

Urology Devices Ecosystem/Market Map

Urology Devices Market Ecosystem

Instruments segment accounted for the largest share of the urology devices industry in 2022, by product.

The urology devices market is categorized into instruments and consumables & accessories based on product. The instruments segment emerged as the dominant force in the market in 2022. The market is being driven by technological advancements coupled with launch of new urology devices and increasing incidence of kidney diseases. Nevertheless, the risk of infections from the repeated utilization of surgical instruments poses a significant hurdle to the market's expansion.

Kidney diseases segment accounted for the largest share in the urology devices industry in 2022, by application.

The global urology devices market is categorized into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications based on application. In 2022, the kidney diseases segment held the largest share in the market, categorized by application. Throughout the world, kidney disease stands as a prominent cause of mortality. Early identification and treatment play a crucial role in minimizing additional kidney harm. Without proper intervention, it can progress to end-stage renal failure. Therefore, the growing incidence of kidney diseases coupled with the health complications associated with them is driving the demand for urological interventions to manage them, which, in turn, is propelling the market for urology devices.

Hospitals, ASCS & clinics segment accounted for the largest share in the urology devices industry in 2022, by end user.

Based on end users, the urology devices market has been segmented into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment accounted for the largest share of the market. Urology diagnostic services and treatments are available across hospitals, ASCs and clinics, each possessing substantial infrastructure for both invasive and non-invasive procedures. These facilities boast advantages such as enhanced and specialized testing options, streamlined billing systems, and cost-effectiveness. Additionally, the growth in the number of ASCs, coupled with the growing number of surgical procedures performed in ASCs, is expected to drive the demand for urology devices in this end-user segment.

North America accounted for the largest share of the urology devices industry in 2022.

The urology devices market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America emerged as the leading contributor, claiming the largest portion of the market share in the urology devices industry. The region has a robust infrastructure for R&D, which has led to the rapid adoption of innovative techniques and platforms. Also, North America houses several major companies operating in the urology devices sector. These companies have significant expertise, resources, and established distribution networks, which contribute to the region's market dominance. Also, the high burden of chronic conditions on regional healthcare systems is another major driver for market growth.

Urology Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The major players in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany). The market leadership of these players stems from their comprehensive product portfolios and expansive global footprint. These dominant market players possess several advantages, including strong marketing and distribution networks, substantial research and development budgets, and well-established brand recognition.

Scope of the Urology Devices Industry

Report Metric	Details
Market Revenue in 2023	$34.1 billion
Projected Revenue by 2028	$48.6 billion
Revenue Rate	Poised to Grow at a CAGR of 7.3%
Market Driver	Rising incidence of urological diseases
Market Opportunity	Potential growth opportunities in emerging economies

This report categorizes the urology devices market to forecast revenue and analyze trends in each of the following submarkets:

By Product

Instruments
Dialysis Devices
- Hemodialysis Devices
- Peritoneal Dialysis Devices
Endoscopes
- Laparoscopes
- Ureteroscopes
- Nephroscopes
- Resectoscopes
- Cystoscopes
Laser & Lithotripsy Devices
Endovision & Imaging Devices
Robotic Systems
Insufflators
Endoscopy Fluid Management Systems
Urodynamic Systems
Other Instruments
Consumables & Accessories
Dialysis Consumables
Catheters
Guidewires
Retrieval Devices & Extractors
Surgical Dissectors, Forceps, & Needle Holders
Dilator Sets & Urethral Access Sheaths
Stents and Implants
Biopsy Devices
Tubes & Distal Attachments
Drainage Bags
Other Consumables & Accessories

By Application

Kidney Diseases
Urological Cancer
Pelvic Organ Prolapse
Benign Prostatic Hyperplasia
Urinary Incontinence
Erectile Dysfunction
Urinary Stones
Other Applications

By End User

Hospitals, ASCS & Clinics
Dialysis Centers
Home Care Settings

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Latin America
Middle East & Africa

Recent Developments of Urology Devices Industry

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.
In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.
In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.
In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)
In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.

Frequently Asked Questions (FAQ):

What is the projected market revenue value of the global urology devices market?

The global urology devices market boasts a total revenue value of $48.6 billion by 2028.

What is the estimated growth rate (CAGR) of the global urology devices market?

The global urology devices market has an estimated compound annual growth rate (CAGR) of 7.3% and a revenue size in the region of $34.1 billion in 2023.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 28)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.3 INCLUSIONS & EXCLUSIONS

1.4 MARKET SCOPE

1.4.1 MARKETS COVERED

1.4.2 REGIONS COVERED

1.4.3 YEARS CONSIDERED

1.4.4 CURRENCY CONSIDERED

1.5 RESEARCH LIMITATIONS

1.6 STAKEHOLDERS

1.7 SUMMARY OF CHANGES

1.7.1 RECESSION IMPACT: UROLOGY DEVICES MARKET

2 RESEARCH METHODOLOGY (Page No. - 34)

2.1 RESEARCH DATA

FIGURE 1 RESEARCH DESIGN

2.1.1 SECONDARY DATA

2.1.1.1 Key data from secondary sources

2.1.2 PRIMARY DATA

2.1.2.1 Primary sources

2.1.2.2 Key data from primary sources

2.1.2.3 Key industry insights

2.1.2.4 Breakdown of primary interviews

FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION

2.2 MARKET SIZE ESTIMATION

2.2.1 BOTTOM-UP APPROACH

FIGURE 4 COMPANY REVENUE ESTIMATION IN UROLOGY DEVICES INDUSTRY

2.2.1.1 Presentations of companies and primary interviews

2.2.1.2 Growth forecast

2.2.1.3 CAGR projections

FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS

2.2.2 TOP-DOWN APPROACH

FIGURE 6 TOP-DOWN APPROACH

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

FIGURE 7 DATA TRIANGULATION METHODOLOGY

2.4 MARKET SHARE ESTIMATION

2.5 STUDY ASSUMPTIONS

2.6 GROWTH RATE ASSUMPTIONS

2.7 RISK ASSESSMENT

TABLE 1 RISK ASSESSMENT: MARKET

2.8 IMPACT OF ECONOMIC RECESSION ON MARKET

3 EXECUTIVE SUMMARY (Page No. - 47)

FIGURE 8 UROLOGY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)

FIGURE 9 UROLOGY DEVICES INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)

FIGURE 10 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)

FIGURE 11 MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 50)

4.1 UROLOGY DEVICES MARKET OVERVIEW

FIGURE 12 RISING PREVALENCE OF UROLOGICAL DISEASES TO DRIVE MARKET

4.2 UROLOGY DEVICES INDUSTRY, BY PRODUCT, 2023 VS. 2028

FIGURE 13 INSTRUMENTS TO DOMINATE MARKET DURING FORECAST PERIOD

4.3 MARKET, BY APPLICATION, 2023 VS. 2028

FIGURE 14 KIDNEY DISEASES TO COMMAND LARGEST MARKET SHARE IN 2028

4.4 MARKET, BY END USER, 2023 VS. 2028

FIGURE 15 HOSPITALS, ASCS, AND CLINICS SEGMENT TO DOMINATE MARKET DURING STUDY PERIOD

4.5 REGIONAL GROWTH OPPORTUNITIES: MARKET

FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD

5 MARKET OVERVIEW (Page No. - 53)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: UROLOGY DEVICES MARKET

5.2.1 DRIVERS

5.2.1.1 Rising incidence of urological diseases

TABLE 2 GLOBAL INCIDENCE OF UROLOGICAL CANCER, 2020

TABLE 3 ESTIMATED NEW UROLOGICAL CANCER CASES AND DEATHS IN US, 2022

5.2.1.2 Growing preference for minimally invasive procedures

TABLE 4 ESTIMATED MARKET SIZE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES, 2021–2030

5.2.1.3 Rising focus on R&D and product launches

5.2.1.4 Growing number of hospitals and surgical centers

5.2.2 RESTRAINTS

5.2.2.1 High degree of consolidation among key players

5.2.3 OPPORTUNITIES

5.2.3.1 Potential growth opportunities in emerging economies

5.2.3.2 Technological advancements

5.2.4 CHALLENGES

5.2.4.1 Increasing number of product recalls by key players

TABLE 5 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2021–2023

5.2.4.2 Shortage of skilled urologists

5.3 PRICING ANALYSIS

TABLE 6 INDICATIVE PRICING FOR UROLOGY DEVICES (IN USD)

5.3.1 AVERAGE SELLING PRICE OF UROLOGY DEVICES

TABLE 7 AVERAGE SELLING PRICE OF UROLOGY DEVICES, BY REGION

5.4 VALUE CHAIN ANALYSIS

FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES

5.5 SUPPLY CHAIN ANALYSIS

FIGURE 19 SUPPLY CHAIN ANALYSIS

5.6 PATENT ANALYSIS

FIGURE 20 PATENT ANALYSIS FOR UROLOGY DEVICES, JANUARY 2013–DECEMBER 2022

TABLE 8 LIST OF MAJOR PATENTS, 2020–2022

5.7 TRADE ANALYSIS

5.7.1 TRADE ANALYSIS FOR UROLOGY DEVICES

TABLE 9 IMPORT DATA FOR DIALYSIS INSTRUMENTS, BY COUNTRY, 2018–2022 (USD MILLION)

TABLE 10 EXPORT DATA FOR DIALYSIS INSTRUMENTS, BY COUNTRY, 2018–2022 (USD MILLION)

5.8 ECOSYSTEM MARKET/MAP

FIGURE 21 ECOSYSTEM MARKET MAP

TABLE 11 ROLE IN ECOSYSTEM

5.9 PORTER’S FIVE FORCES ANALYSIS

TABLE 12 PORTER’S FIVE FORCES

5.9.1 THREAT OF NEW ENTRANTS

5.9.2 THREAT OF SUBSTITUTES

5.9.3 BARGAINING POWER OF SUPPLIERS

5.9.4 BARGAINING POWER OF BUYERS

5.9.5 INTENSITY OF COMPETITIVE RIVALRY

5.10 PESTLE ANALYSIS

5.11 REGULATORY ANALYSIS

TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.11.1 NORTH AMERICA

5.11.1.1 US

5.11.1.2 Canada

5.11.2 EUROPE

5.11.3 ASIA PACIFIC

5.11.3.1 China

5.11.3.2 Japan

5.11.3.3 India

5.11.4 LATIN AMERICA

5.11.4.1 Brazil

5.11.4.2 Mexico

5.11.5 MIDDLE EAST

5.11.6 AFRICA

5.12 KEY CONFERENCES & EVENTS

TABLE 17 DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2023–2024

5.13 TECHNOLOGY ANALYSIS

5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

FIGURE 22 REVENUE SHIFT IN MARKET

5.15 KEY STAKEHOLDERS & BUYING CRITERIA

5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS

FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UROLOGY DEVICES

TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UROLOGY DEVICES (%)

5.15.2 BUYING CRITERIA

FIGURE 24 KEY BUYING CRITERIA FOR END USERS OF UROLOGY DEVICES

TABLE 19 KEY BUYING CRITERIA, BY END USER

5.16 CASE STUDY ANALYSIS

5.16.1 CASE STUDY: IDENTIFICATION OF FACTORS FOR SURGICAL ADVANCEMENTS

6 UROLOGY DEVICES MARKET, BY PRODUCT (Page No. - 81)

6.1 INTRODUCTION

TABLE 20 UROLOGY DEVICES INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)

6.1.1 PRIMARY NOTES

6.1.1.1 Key industry insights

6.2 INSTRUMENTS

TABLE 21 MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)

TABLE 22 MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

6.2.1 DIALYSIS DEVICES

TABLE 23 DIALYSIS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)

TABLE 24 DIALYSIS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)

6.2.1.1 Hemodialysis devices

6.2.1.1.1 Technological advancements and increased need for home dialysis to drive segment

TABLE 25 HEMODIALYSIS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.1.2 Peritoneal dialysis devices

6.2.1.2.1 Cost-effectiveness and lesser time consumption to drive segment

TABLE 26 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.2 ENDOSCOPES

TABLE 27 ENDOSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)

TABLE 28 ENDOSCOPES MARKET, BY TYPE, 2021–2028 (USD MILLION)

6.2.2.1 Laparoscopes

6.2.2.1.1 Lower surgical-site infection and faster recovery rates to drive segment

TABLE 29 LAPAROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.2.2 Ureteroscopes

6.2.2.2.1 Technological advancements and development of advanced ureteroscopy for kidney stones to drive segment

TABLE 30 URETEROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.2.3 Nephroscopes

6.2.2.3.1 Increasing incidence of chronic kidney diseases to drive segment

TABLE 31 NEPHROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.2.4 Resectoscopes

6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive segment

TABLE 32 RESECTOSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.2.5 Cystoscopes

6.2.2.5.1 Increasing prevalence of urological cancers to drive segment

TABLE 33 CYSTOSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.3 LASER & LITHOTRIPSY DEVICES

6.2.3.1 Increasing prevalence of kidney stones to drive segment

TABLE 34 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.4 ENDOVISION & IMAGING SYSTEMS

6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to drive segment

TABLE 35 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.5 ROBOTIC SYSTEMS

6.2.5.1 Increasing public-private collaborations for research on minimally-invasive surgeries to drive segment

TABLE 36 ROBOTIC SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.6 INSUFFLATORS

6.2.6.1 Increasing number of laparoscopic surgeries to drive segment

TABLE 37 INSUFFLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS

6.2.7.1 Ease of use, improved safety, and lesser medical expense to drive segment

TABLE 38 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.8 URODYNAMIC SYSTEMS

6.2.8.1 Growing patient pool in emerging economies to drive segment

TABLE 39 URODYNAMIC SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.9 OTHER INSTRUMENTS

TABLE 40 OTHER INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3 CONSUMABLES & ACCESSORIES

TABLE 41 MARKET FOR CONSUMABLES & ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)

TABLE 42 MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)

6.3.1 DIALYSIS CONSUMABLES

6.3.1.1 Increasing use of dialyzers and rising number of repeat purchases to drive segment

TABLE 43 DIALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.2 CATHETERS

6.3.2.1 High prevalence of urinary incontinence and increased number of surgical procedures to drive segment

TABLE 44 CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.3 GUIDEWIRES

6.3.3.1 Development of next-generation hybrid guidewires and increased applications in endoscopy to drive segment

TABLE 45 GUIDEWIRES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.4 RETRIEVAL DEVICES & EXTRACTORS

6.3.4.1 Growing number of kidney stone removal surgeries to drive market

TABLE 46 RETRIEVAL DEVICES & EXTRACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.5 SURGICAL DISSECTORS, FORCEPS, AND NEEDLE HOLDERS

6.3.5.1 Growing number of urology procedures and increasing prevalence of chronic kidney diseases to drive segment

TABLE 47 SURGICAL DISSECTORS, FORCEPS, AND NEEDLE HOLDERS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS

6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to drive segment

TABLE 48 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.7 STENTS & IMPLANTS

6.3.7.1 Growing prevalence of kidney-related disorders and erectile dysfunction to drive segment

TABLE 49 STENTS & IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION

6.3.8 BIOPSY DEVICES

6.3.8.1 High incidence of prostate cancer among male geriatric population to drive segment

TABLE 50 BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.9 TUBES & DISTAL ATTACHMENTS

6.3.9.1 Growing demand for endoscopy and colonoscopy procedures to drive market

TABLE 51 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.10 DRAINAGE BAGS

6.3.10.1 Increased risk of urinary tract infections to limit market

TABLE 52 DRAINAGE BAGS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.11 OTHER CONSUMABLES & ACCESSORIES

TABLE 53 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)

7 UROLOGY DEVICES MARKET, BY APPLICATION (Page No. - 115)

7.1 INTRODUCTION

TABLE 54 UROLOGY DEVICES INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)

7.2 KIDNEY DISEASES

7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET

TABLE 55 MARKET FOR KIDNEY DISEASES, BY REGION, 2021–2028 (USD MILLION)

7.3 UROLOGICAL CANCER

7.3.1 RISING PREVALENCE OF SURGERIES FOR UROLOGICAL CANCER TREATMENT TO DRIVE MARKET

TABLE 56 MARKET FOR UROLOGICAL CANCER, BY REGION, 2021–2028 (USD MILLION)

7.4 PELVIC ORGAN PROLAPSE

7.4.1 HIGH COSTS OF SURGERIES AND LACK OF EFFECTIVE PELVIC ORGAN PROLAPSE TREATMENT TO LIMIT MARKET

TABLE 57 MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2021–2028 (USD MILLION)

7.5 BENIGN PROSTATIC HYPERPLASIA

7.5.1 GROWING GERIATRIC POPULATION AND IMPROVING TREATMENT OPTIONS TO DRIVE MARKET

TABLE 58 MARKET FOR BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2021–2028 (USD MILLION)

7.6 URINARY INCONTINENCE

7.6.1 GROWING PREVALENCE OF URINARY INCONTINENCE IN OLDER POPULATION TO DRIVE MARKET

TABLE 59 ESTIMATED PREVALENCE FOR TYPES OF URINARY INCONTINENCE, 2022

TABLE 60 MARKET FOR BENIGN URINARY INCONTINENCE, BY REGION, 2021–2028 (USD MILLION)

7.7 ERECTILE DYSFUNCTION

7.7.1 RISING PREVALENCE OF PROSTATE CANCER TO DRIVE MARKET

TABLE 61 MARKET FOR ERECTILE DYSFUNCTION, BY REGION, 2021–2028 (USD MILLION)

7.8 URINARY STONES

7.8.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET

TABLE 62 MARKET FOR URINARY STONES, BY REGION, 2021–2028 (USD MILLION)

7.9 OTHER APPLICATIONS

TABLE 63 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)

8 UROLOGY DEVICES MARKET, BY END USER (Page No. - 126)

8.1 INTRODUCTION

TABLE 64 UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

8.2 HOSPITALS, ASCS, AND CLINICS

8.2.1 HOSPITALS, ASCS, AND CLINICS SEGMENT TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD

TABLE 65 MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION)

8.3 DIALYSIS CENTERS

8.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS PRODUCTS AND FACILITIES TO DRIVE MARKET

TABLE 66 NUMBER OF DIALYSIS CENTERS IN US, BY COMPANY, 2022

TABLE 67 MARKET FOR DIALYSIS CENTERS, BY REGION, 2021–2028 (USD MILLION)

8.4 HOME CARE SETTINGS

8.4.1 UNAVAILABILITY OF DIALYSIS CENTERS IN EMERGING ECONOMIES TO DRIVE MARKET

TABLE 68 MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION)

9 UROLOGY DEVICES MARKET, BY REGION (Page No. - 132)

9.1 INTRODUCTION

TABLE 69 UROLOGY DEVICES INDUSTRY, BY REGION, 2021–2028 (USD MILLION)

9.2 NORTH AMERICA

FIGURE 25 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT

TABLE 70 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 71 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 72 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 73 NORTH AMERICA: UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

9.2.1 NORTH AMERICA: RECESSION IMPACT

9.2.2 US

9.2.2.1 US to dominate North American urology devices market during forecast period

TABLE 74 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 75 US: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 76 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 77 US: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.2.3 CANADA

9.2.3.1 Rising prevalence of urological cancers and diabetes to drive market

TABLE 78 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 79 CANADA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 80 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 81 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.3 EUROPE

TABLE 82 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 83 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 84 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 85 EUROPE: UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

9.3.1 EUROPE: RECESSION IMPACT

9.3.2 GERMANY

9.3.2.1 Rising geriatric population and growing incidence of urological cancers to drive market

TABLE 86 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 87 GERMANY: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 88 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 89 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.3.3 UK

9.3.3.1 Rising incidence of kidney diseases and better reimbursement policies for dialysis to drive market

TABLE 90 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 91 UK: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 92 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 93 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.3.4 FRANCE

9.3.4.1 Favorable government initiatives and rising number of surgical procedures to drive market

TABLE 94 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 95 FRANCE: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 96 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 97 FRANCE: UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

9.3.5 ITALY

9.3.5.1 Increasing cases of chronic kidney diseases and rising geriatric population to drive market

TABLE 98 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 99 ITALY: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 100 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 101 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.3.6 SPAIN

9.3.6.1 Increasing government initiatives and healthcare funding to drive market

TABLE 102 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 103 SPAIN: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 104 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 105 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.3.7 REST OF EUROPE

TABLE 106 REST OF EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 107 REST OF EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 108 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 109 REST OF EUROPE: UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

9.4 ASIA PACIFIC

FIGURE 26 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT

TABLE 110 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 111 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 112 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 113 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.4.1 ASIA PACIFIC: RECESSION IMPACT

9.4.2 CHINA

9.4.2.1 Improving healthcare infrastructure and rising disposable income of middle-class population to drive market

TABLE 114 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 115 CHINA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 116 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 117 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.4.3 JAPAN

9.4.3.1 Well-established healthcare system and large geriatric population to drive market

TABLE 118 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 119 JAPAN: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 120 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 121 JAPAN: UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

9.4.4 INDIA

9.4.4.1 Improvement in healthcare infrastructure and presence of large patient pool to drive market

TABLE 122 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 123 INDIA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 124 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 125 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.4.5 REST OF ASIA PACIFIC

TABLE 126 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 127 REST OF ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 128 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 129 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.5 LATIN AMERICA

9.5.1 RISING PREVALENCE OF CHRONIC DISEASES AND GROWING PATIENT POOL TO DRIVE MARKET

TABLE 130 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 131 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 132 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 133 LATIN AMERICA: UROLOGY DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)

9.5.2 LATIN AMERICA: RECESSION IMPACT

9.6 MIDDLE EAST & AFRICA

9.6.1 INCREASING HEALTHCARE EXPENDITURE AND IMPROVING HEALTHCARE SYSTEM TO DRIVE MARKET

TABLE 134 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 135 MIDDLE EAST & AFRICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)

TABLE 136 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 137 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)

9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE (Page No. - 181)

10.1 OVERVIEW

10.2 KEY STRATEGIES/RIGHT TO WIN

TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN UROLOGY DEVICES MARKET

10.3 REVENUE SHARE ANALYSIS

FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS

10.4 MARKET SHARE ANALYSIS

FIGURE 28 UROLOGY DEVICES INDUSTRY SHARE, BY KEY PLAYER, 2022

TABLE 139 DEGREE OF COMPETITION: UROLOGY DEVICES INDUSTRY

10.5 COMPANY EVALUATION MATRIX

10.5.1 STARS

10.5.2 EMERGING LEADERS

10.5.3 PERVASIVE PLAYERS

10.5.4 PARTICIPANTS

FIGURE29 COMPANY EVALUATION MATRIX, 2022

10.5.5 COMPANY FOOTPRINT

FIGURE30 PRODUCT AND REGIONAL FOOTPRINT

TABLE 140 PRODUCT FOOTPRINT

TABLE 141 REGIONAL FOOTPRINT

10.6 SME/START-UP EVALUATION MATRIX

10.6.1 PROGRESSIVE COMPANIES

10.6.2 RESPONSIVE COMPANIES

10.6.3 DYNAMIC COMPANIES

10.6.4 STARTING BLOCKS

FIGURE31 START-UP/SME EVALUATION MATRIX, 2022

10.6.5 COMPETITIVE BENCHMARKING

TABLE 142 COMPETITIVE BENCHMARKING OF KEY PLAYERS

TABLE 143 DETAILED LIST OF KEY START-UPS/SMES

10.7 COMPETITIVE SCENARIOS AND TRENDS

10.7.1 KEY PRODUCT LAUNCHES & APPROVALS

TABLE 144 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–OCTOBER 2023

10.7.2 KEY DEALS

TABLE 145 KEY DEALS, JANUARY 2020–OCTOBER 2023

10.7.3 OTHER KEY DEVELOPMENTS

TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2020–OCTOBER 2023

11 COMPANY PROFILES (Page No. - 195)

(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

11.1 KEY PLAYERS

11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA

TABLE 147 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW

FIGURE32 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2022)

11.1.2 BAXTER INTERNATIONAL, INC.

TABLE 148 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW

FIGURE33 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)

11.1.3 BOSTON SCIENTIFIC CORPORATION

TABLE 149 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW

FIGURE34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)

11.1.4 BECTON, DICKINSON AND COMPANY

TABLE 150 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW

FIGURE35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)

11.1.5 B. BRAUN MELSUNGEN AG

TABLE 151 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW

FIGURE36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)

11.1.6 CARDINAL HEALTH

TABLE 152 CARDINAL HEALTH: COMPANY OVERVIEW

FIGURE37 CARDINAL HEALTH: COMPANY SNAPSHOT (2022)

11.1.7 OLYMPUS CORPORATION

TABLE 153 OLYMPUS CORPORATION: COMPANY OVERVIEW

FIGURE38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)

11.1.8 INTUITIVE SURGICAL

TABLE 154 INTUITIVE SURGICAL: COMPANY OVERVIEW

FIGURE39 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2022)

11.1.9 COLOPLAST A/S

TABLE 155 COLOPLAST A/S: COMPANY OVERVIEW

FIGURE40 COLOPLAST A/S: COMPANY SNAPSHOT (2022)

11.1.10 STRYKER CORPORATION

TABLE 156 STRYKER CORPORATION: COMPANY OVERVIEW

FIGURE41 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)

11.1.11 TELEFLEX INCORPORATED

TABLE 157 TELEFLEX INCORPORATED: COMPANY OVERVIEW

FIGURE42 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)

11.1.12 CONVATEC GROUP PLC

TABLE 158 CONVATEC GROUP PLC: COMPANY OVERVIEW

FIGURE43 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2022)

11.1.13 MEDTRONIC PLC

TABLE 159 MEDTRONIC PLC: COMPANY OVERVIEW

FIGURE44 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)

11.2 OTHER PLAYERS

11.2.1 KARL STORZ

11.2.2 COOK MEDICAL

11.2.3 RICHARD WOLF GMBH

11.2.4 COMPACTCATH

11.2.5 DORNIER MEDTECH

11.2.6 NIKKISO CO., LTD.

11.2.7 DIALIFE SA

11.2.8 ERBE VISION

11.2.9 WELL LEAD MEDICAL CO., LTD.

11.2.10 ROCAMED

11.2.11 ENDOMED SYSTEMS GMBH

11.2.12 AMSINO INTERNATIONAL, INC.

11.2.13 MEDISPEC

11.2.14 MEDICAL TECHNOLOGIES OF GEORGIA

11.2.15 VIMEX SP. Z O. O.

11.2.16 BALTON SP. Z O.O.

11.2.17 HUNTER UROLOGY (PART OF OPTIMUM MEDICAL GROUP)

11.2.18 RIBBEL INTERNATIONAL LIMITED

*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 268)

12.1 DISCUSSION GUIDE

12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

12.3 CUSTOMIZATION OPTIONS

12.4 RELATED REPORTS

12.5 AUTHOR DETAILS

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, and key player strategies. To track company developments such as product launches, agreements, collaborations, partnerships, expansions, and acquisitions of the leading players, the competitive landscape of the urology devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Urology Devices Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME	DESIGNATION
Baxter International, Inc.	Senior Product Manager
Cardinal Health	Quality Control Manager
Becton, Dickinson and Company	Marketing Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the urology devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry have been identified through extensive secondary research
The revenues generated by leading players operating in the urology devices market have been determined through primary and secondary research.
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Urology Devices Market Size: Bottom Up Approach

Urology Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Urology Devices Market Size: Top-Down Approach

Urology Devices Market Size, and Share

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices consist of various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.

Key Stakeholders

Manufacturers and distributors of urology devices
Hospitals and ASCs
Academic research institutes
Urology clinics
Urology device service providers
Venture capitalists and investors
Clinical research organizations (CROs)

Report Objectives

To define, describe, and forecast the urology devices market by product, application, end user, and region
To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall urology devices market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies2 in terms of market developments and growth strategies
To track and analyze competitive developments such as product launches, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

MarketsandMarkets offers the following customizations for this market report.

Country Information

Additional country-level analysis of the urology devices market

Company profiles

Additional five company profiles of players operating in the urology devices market.

Product Analysis

Product matrix, which provides a detailed comparison of the product portfolio of each company in the urology devices market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.